NASDAQ · OSUR

OraSure Technologies Inc.

$3.97 -$0.06 (-1.49%) 1D After hours

Key Metrics

$277.46M
Market cap
P/E · TTM
$113.02M
Revenue · TTM
−$75.07M
Net income
EPS · TTM $-1.00
Dividend yield
Free cash flow −$47.88M
Beta · 1Y 1.06
EBITDA · TTM −$60.38M
Gross margin 42.2%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 22
    The stock moved +9.7% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 22
  • Feb 26
    The stock moved +10.0% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 26

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$277.46M
Enterprise value
Shares outstanding68.8M
52-wk range$2.08 – $4.58
Avg volume · 20D788.0K
Net cash
Book value / share$4.19
IndustrySurgical & Medical Instruments & Apparatus
ExchangeNASDAQ
About OraSure Technologies Inc.
IPO dateNov 17, 1986
Employees500

OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S2.46
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross 42.2%
Operating -62.0%
Net -66.4%
FCF -42.4%
ROE / ROIC -20.7% · -52.7%

Financial Health

Current ratio5.46
Quick ratio4.77
Debt / equity
Debt / EBITDA
Net cash
Working capital$196.70M

Cash Flow · TTM

Operating CF −$43.19M
Capex −$4.69M
Free cash flow −$47.88M
Buybacks $19.10M
Dividends paid
Shareholder yield 6.9%

Piotroski F-Score

1 / 9
Weak fundamentals · 1 of 9 signals passing

Altman Z-Score

2.1
Grey zone (1.81–2.99) · monitor

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings